Alan Olby

Alan Olby

Director of Finance/CFO chez INSPIRATION HEALTHCARE GROUP PLC

Fortune : 15 557 $ au 31/03/2024

53 ans
Health Technology
Commercial Services
Finance

Profil

Alan Musgrave Olby is currently the Chief Financial Officer & Director at Inspiration Healthcare Group Plc since 2023.
He also holds a current position at Deloitte Touche Tohmatsu Services LLC since 2004.
Previously, he worked as the Chief Financial Officer & Executive Director at Sinclair Pharma Ltd.
from 2005 to 2022.
He also held various director positions at Sinclair Pharmaceutical España SL (Spain), Sinclair Pharmaceuticals Ltd., Sinclair Pharma Holdings Ltd., Sinclair Pharma Management Ltd., and IS Pharmaceuticals Ltd.
Additionally, he worked as the Group Financial Controller at Xenova Group Plc and KS Biomedix Plc.
He started his career as an Audit Manager at Baker Tilly & Co. Ltd.
and Finance Manager at Deloitte LLP (United Kingdom).

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
16/10/2023 43 211 ( 0,06% ) 15 557 $ 31/03/2024

Postes actifs de Alan Olby

SociétésPosteDébut
INSPIRATION HEALTHCARE GROUP PLC Director of Finance/CFO 12/06/2023
Tous les postes actifs de Alan Olby

Anciens postes connus de Alan Olby

SociétésPosteFin
SINCLAIR PHARMA PLC Director of Finance/CFO -
Director of Finance/CFO 07/10/2009
IS Pharmaceuticals Ltd. Director/Board Member -
Director/Board Member -
Director/Board Member -
Voir l'expérience en détail de Alan Olby

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Alan Olby

Relations

42

Relations au 1er degré

12

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées1
INSPIRATION HEALTHCARE GROUP PLC

Health Technology

Entreprise privées11

Commercial Services

Health Technology

Commercial Services

KS Biomedix Plc

Consumer Non-Durables

Commercial Services

Health Technology

Health Technology

Finance

Finance

IS Pharmaceuticals Ltd.

Voir les connexions sociétés